Q: I just learned I have prediabetes. I also learned that a lot of people with pancreatic cancer have trouble with blood ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary ...

Kauvery Hospital Vadapalani, a leading healthcare institution renowned for its advanced surgical techniques, has performed a ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial ...